Satori 2017

The Satori is a student literary publication that expresses the artistic spirit of the students of Winona State University. Student poetry, prose, and graphic art are published in the Satori every spring since 1970. The Satori 2017 editors are: Editor-in-Chief: Sajda Omar Poetry Editor: Karl Hanson Art/Design Editor: Danielle Eberhard Prose Editor: Cassie Douglas Poetry Committee: Kelly Johnson and Lydia Papenfuss Art/Design Committee: Aurie Brighton and Xinyue Wang Prose Committee: Katie McCoy, Madison Wilke, Megan Back, Alayna Godfrey, Madelyn Hall, and Sam Stormoen Faculty Advisor: Dr. Gary Eddy, Professor of Englishhttps://openriver.winona.edu/satori/1013/thumbnail.jp

NASA's In-Space Propulsion Technology Program: Overview and Status

NASA's In-Space Propulsion Technology Program is investing in technologies that have the potential to revolutionize the robotic exploration of deep space. For robotic exploration and science missions, increased efficiencies of future propulsion systems are critical to reduce overall life-cycle costs and, in some cases, enable missions previously considered impossible. Continued reliance on conventional chemical propulsion alone will not enable the robust exploration of deep space - the maximum theoretical efficiencies have almost been reached and they are insufficient to meet needs for many ambitious science missions currently being considered. The In-Space Propulsion Technology Program s technology portfolio includes many advanced propulsion systems. From the next generation ion propulsion system operating in the 5 - 10 kW range, to advanced cryogenic propulsion, substantial advances in spacecraft propulsion performance are anticipated. Some of the most promising technologies for achieving these goals use the environment of space itself for energy and propulsion and are generically called, 'propellantless' because they do not require onboard fuel to achieve thrust. Propellantless propulsion technologies include scientific innovations such as solar sails, electrodynamic and momentum transfer tethers, aeroassist, and aerocapture. This paper will provide an overview of both propellantless and propellant-based advanced propulsion technologies, and NASA s plans for advancing them as part of the $60M per year In-Space Propulsion Technology Program

NASA In-Space Propulsion Technology Program: Overview and Update

NASA's In-Space Propulsion Technology Program is investing in technologies that have the potential to revolutionize the robotic exploration of deep space. For robotic exploration and science missions, increased efficiencies of future propulsion systems are critical to reduce overall life-cycle costs and, in some cases, enable missions previously considered impossible. Continued reliance on conventional chemical propulsion alone will not enable the robust exploration of deep space - the maximum theoretical efficiencies have almost been reached and they are insufficient to meet needs for many ambitious science missions currently being considered. The In-Space Propulsion Technology Program's technology portfolio includes many advanced propulsion systems. From the next-generation ion propulsion system operating in the 5- to 10-kW range to aerocapture and solar sails, substantial advances in - spacecraft propulsion performance are anticipated. Some of the most promising technologies for achieving these goals use the environment of space itself for energy and propulsion and are generically called 'propellantless' because they do not require onboard fuel to achieve thrust. Propellantless propulsion technologies include scientific innovations such as solar sails, electrodynamic and momentum transfer.tethers, aeroassist and aerocapture. This paper will provide an overview of both propellantless and propellant-based advanced propulsion technologies, as well as NASA's plans for advancing them as part of the In-Space Propulsion Technology Program

Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy

The field of radionuclide therapy (RNT) for prostate cancer (PC) is growing rapidly, with recent Food and Drug Administration approval of the first 177Lu-PSMA ligand. We aimed to develop the first patient-reported outcome (PRO) measure for PC patients receiving RNT. Methods: We identified relevant symptoms and toxicities by reviewing published trials and interviews with PC patients receiving RNT (n = 29), caregivers (n = 14), and clinicians (n = 11). Second, we selected items for measure inclusion. Third, we refined the item list with input from experts in RNTs and PROs. Fourth, we finalized the Functional Assessment of Cancer Therapy-Radionuclide Therapy (FACT-RNT) with patient input. Results: This multistep process yielded a brief 15-item measure deemed by key stakeholders to be relevant and useful in the context of RNT for PC. Conclusion: The FACT-RNT is a new standardized tool to monitor relevant symptoms and toxicities among PC patients in RNT trials and real-world settings

Cardiovascular Effects of Chemotherapy Used in the Treatment of Breast Cancers

Attempts to carry out clinical trials to improve the treatment of breast cancers, including chemotherapy and targeted oncologic therapies, often exclude women with baseline cardiovascular compromise, such as low ejection fraction or arrhythmia. Therefore, despite concrete evidence of cardiotoxicity from a select number of chemotherapeutic agents, it has been difficult to better characterize the progression of cardiac dysfunction in women with preexisting cardiac conditions who receive chemotherapy. Women who have impaired cardiac function should be included in future clinical trials, or at least placed in separate trials with careful monitoring, to better assess this high-risk population. This article will discuss the epidemiology, mechanisms, diagnostic methods, and management of cardiotoxicity from systemic chemotherapy used to treat breast cancer